Pharmafile Logo
Pharmafocus logo
Advanced Search

Financing

Showing 6 posts of 6 posts found.

PureTech Health launches Seaport Therapeutics

April 9, 2024
Business Services Financing, Neurology, PureTech Health, launch

PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to patients and unlock value for …

News

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023
Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies

US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …

News

Renibus Therapeutics announces $47m financing for phase 3 trial

July 19, 2023
Business Services Cardiology, Financing, Renibus Therapeutics, clinical trial

Clinical stage biopharmaceutical company Renibus Therapeutics has announced that it has raised $47m from the initial closing of its Series …

News

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023
Sales and Marketing ElevateBio, Financing, cell and gene therapies

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

News

Nido Biosciences raises $109m in funding for neurological diseases treatments

May 16, 2023
Sales and Marketing Financing, Neurology, Nido Biosciences, funding, neurology

US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …

News

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021
Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024